Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Electroretinogram: a New Human Biomarker for Smoking Cessation Treatment

NCT03213418 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.

NCT NCT03213418
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03213418 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Electroretinogram: a New Human Biomarker for Smoking Cessation Treatment
Lead sponsor
New York State Psychiatric Institute
Phase
Not applicable
Overall status
Terminated
Start date
February 1, 2018
Completion date
December 1, 2022
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cigarette smoking, nicotine dependence, nicotine use disorder, smoking, smoking cessation, smoking, cigarette, tobacco dependence, tobacco smoking, tobacco use, tobacco use disorder